Get ahead of standard cancer treatment. Participating in an acute myeloid leukemia clinical trial gives you access to the latest therapies.
Compliant with
You can receive a guidebook with information about leukemia cancer by filling out the form.
If your acute myeloid leukemia (AML) isn’t responding to treatment (sometimes called refractory AML) or you have experienced an AML relapse (meaning your cancer returned after initially responding to treatment), you may feel like you are running out of opportunities to beat this disease.
However, if you have a worrisome acute myeloid leukemia prognosis, Massive Bio can help you find advanced treatment options. Massive Bio assists patients who want to find and enroll in AML clinical trials of innovative new treatments.
What Are Clinical Trials?
A clinical trial is a research study in which scientists evaluate the effectiveness and safety of new medical treatments. That includes new drugs or novel combinations of drugs for treating cancer and other diseases. Every drug approved by the U.S. Food and Drug Administration had to be tested first in clinical trials.
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.
Access the free matching toolMassive Bio offers a quick, easy, and FREE way to find clinical trials for patients like you who are searching for new AML treatment options. With our unique clinical trial matching system and compassionate team, Massive Bio can rapidly match you to clinical trials of innovative new acute myeloid leukemia medications. If you aren’t sure what your AML prognosis is, that’s okay—we’re here to help.
Talk to us. Our nurses and patient relations coordinators are here and happy to help you. You are not alone in this fight.
Call +1 844 627 7246Clinical trials test the latest scientific advancements in Non-Small Cell Lung Cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Non-Small Cell Lung Cancer patients might gain access to promising drugs and innovative treatments long before they're made available to the public.
You are not alone
You can have an experienced team with you
Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new treatments. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important treatment option for many cancer patients.
We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.
Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.
They have a really responsive and hard-working team. It’s a great way to explore clinical cancer trials and find alternative treatments.
Massive Bio helped me understand the importance and benefits of clinical trials, then found personalized matches using an AI database and recommended a nearby trial to enroll in. Their customer service was helpful in answering any questions about the services and process.
My father used the Virtual Tumor Board to get another treatment recommendation. The report was detailed, and the staff answered all our questions. I definitely recommend their services.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.